Marcel J. Van Gelderen
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Randomized controlled trial of multi-modular motion-assisted memory desensitization and reconsolidation (3MDR) for male military veterans with treatment-resistant post-traumatic stress disorder.
Journal: Acta psychiatrica Scandinavica
Published: May 28, 2020
Efficacy of immersive PTSD treatments: A systematic review of virtual and augmented reality exposure therapy and a meta-analysis of virtual reality exposure therapy.
Journal: Journal of psychiatric research
Published: May 18, 2020
An Exploratory Study in Healthy Male Subjects of the Mechanism of Mirabegron-Induced Cardiovascular Effects.
Journal: Journal of clinical pharmacology
Published: February 13, 2017
Pharmacokinetic Interactions Between Mirabegron and Metformin, Warfarin, Digoxin or Combined Oral Contraceptives.
Journal: European journal of drug metabolism and pharmacokinetics
Published: June 29, 2016
Pharmacokinetics of Mirabegron, a β3-Adrenoceptor Agonist for Treatment of Overactive Bladder, in Healthy East Asian Subjects.
Journal: Clinical therapeutics
Published: December 05, 2014
Absence of clinically relevant cardiovascular interaction upon add-on of mirabegron or tamsulosin to an established tamsulosin or mirabegron treatment in healthy middle-aged to elderly men.
Journal: International journal of clinical pharmacology and therapeutics
Published: April 24, 2014
Pharmacokinetics of mirabegron, a β3-adrenoceptor agonist for treatment of overactive bladder, in healthy Japanese male subjects: results from single- and multiple-dose studies.
Journal: Clinical drug investigation
Published: November 02, 2013
Role of cytochrome p450 isoenzymes 3A and 2D6 in the in vivo metabolism of mirabegron, a β3-adrenoceptor agonist.
Journal: Clinical drug investigation
Published: April 30, 2013
Effect of renal or hepatic impairment on the pharmacokinetics of mirabegron.
Journal: Clinical drug investigation
Published: December 05, 2012
Effects of food intake on the pharmacokinetic properties of mirabegron oral controlled-absorption system: a single-dose, randomized, crossover study in healthy adults.
Journal: Clinical therapeutics
Published: October 23, 2012
Single dose pharmacokinetics and absolute bioavailability of mirabegron, a β₃-adrenoceptor agonist for treatment of overactive bladder.
Journal: International journal of clinical pharmacology and therapeutics
Published: September 05, 2012
Pharmacokinetic properties of mirabegron, a β3-adrenoceptor agonist: results from two phase I, randomized, multiple-dose studies in healthy young and elderly men and women.
Journal: Clinical therapeutics
Published: June 26, 2012
Last Updated: 09/26/2026